KEI Research Note: 2020-4: The current and potential role of biomedical research mandates 2020 The current and potential role of biomedical research mandates. Progress in biomedical research depends upon funding. This funding comes from a variety of public sector, non-profit… Continue Reading
In the United States Senate, the Committee on Health, Education, Labor and Pensions (HELP) is trying to move forward a bill titled the “Food and Drug Administration Safety and Innovation Act.” Among other things, the bill would “amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, establish user-fee programs for generic drugs and biosimilars,” and address a number of other topics, such as extend the legal monopoly on antibiotic drugs by 5 years. Continue Reading